Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53

Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE 2 synthase but can metabolize PGH 2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPG...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 14; no. 10; pp. 710 - 12
Main Authors Zhong, Dandan, Quan, Lingling, Hao, Chang, Chen, Jingshuo, Qiao, Ranran, Lin, Tengfei, Ying, Changjiang, Sun, Dong, Jia, Zhanjun, Sun, Ying
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 31.10.2023
Springer Nature B.V
Nature Publishing Group
Subjects
13/1
13/109
13/89
14/19
14/28
45/90
45/91
631/80/82
692/699/1585/4
Antibodies
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cell Culture
Cell injury
Cisplatin
Ferroptosis
Heme
Immunology
Ischemia
Kidneys
Life Sciences
Morbidity
p53 Protein
Prostaglandin E
Prostaglandin E2
Renal function
Reperfusion
Online AccessGet full text

Cover

Abstract Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE 2 synthase but can metabolize PGH 2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.
AbstractList Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE2 synthase but can metabolize PGH2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.
Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE 2 synthase but can metabolize PGH 2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.
Abstract Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE2 synthase but can metabolize PGH2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.
Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE2 synthase but can metabolize PGH2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is a PGE2 synthase but can metabolize PGH2 to malondialdehyde by forming a complex with heme. However, the role and mechanism of action of mPGES-2 in AKI remain unclear. To examine the role of mPGES-2, both global and tubule-specific mPGES-2-deficient mice were treated with cisplatin to induce AKI. mPGES-2 knockdown or overexpressing HK-2 cells were exposed to cisplatin to cause acute renal tubular cell injury. The mPGES-2 inhibitor SZ0232 was used to test the translational potential of targeting mPGES-2 in treating AKI. Additionally, mice were subjected to unilateral renal ischemia/reperfusion to further validate the effect of mPGES-2 on AKI. Interestingly, both genetic and pharmacological blockage of mPGES-2 led to decreased renal dysfunction and morphological damage induced by cisplatin and unilateral renal ischemia/reperfusion. Mechanistic exploration indicated that mPGES-2 deficiency inhibited ferroptosis via the heme-dependent regulation of the p53/SLC7A11/GPX4 axis. The present study indicates that mPGES-2 blockage may be a promising therapeutic strategy for AKI.
ArticleNumber 710
Author Sun, Ying
Chen, Jingshuo
Zhong, Dandan
Ying, Changjiang
Jia, Zhanjun
Quan, Lingling
Sun, Dong
Hao, Chang
Lin, Tengfei
Qiao, Ranran
Author_xml – sequence: 1
  givenname: Dandan
  surname: Zhong
  fullname: Zhong, Dandan
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University
– sequence: 2
  givenname: Lingling
  surname: Quan
  fullname: Quan, Lingling
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University
– sequence: 3
  givenname: Chang
  surname: Hao
  fullname: Hao, Chang
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University
– sequence: 4
  givenname: Jingshuo
  surname: Chen
  fullname: Chen, Jingshuo
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Nanjing Key Laboratory of Pediatrics, Children’s Hospital of Nanjing Medical University
– sequence: 5
  givenname: Ranran
  surname: Qiao
  fullname: Qiao, Ranran
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Public Experimental Research Center of Xuzhou Medical University, Xuzhou Medical University
– sequence: 6
  givenname: Tengfei
  surname: Lin
  fullname: Lin, Tengfei
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University
– sequence: 7
  givenname: Changjiang
  surname: Ying
  fullname: Ying, Changjiang
  organization: Department of Endocrinology, Affiliated Hospital of Xuzhou Medical University, Institute of Nephrology, Xuzhou Medical University
– sequence: 8
  givenname: Dong
  surname: Sun
  fullname: Sun, Dong
  organization: Institute of Nephrology, Xuzhou Medical University, Department of Nephrology, Affiliated Hospital of Xuzhou Medical University
– sequence: 9
  givenname: Zhanjun
  orcidid: 0000-0002-3107-0429
  surname: Jia
  fullname: Jia, Zhanjun
  email: jiazj72@hotmail.com
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Nanjing Key Laboratory of Pediatrics, Children’s Hospital of Nanjing Medical University
– sequence: 10
  givenname: Ying
  orcidid: 0000-0002-1720-8540
  surname: Sun
  fullname: Sun, Ying
  email: yingsun@xzhmu.edu.cn
  organization: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University
BookMark eNp9Uk1v1DAQjVARLaV_gJMlLlwC_o59QqgqpVIlkChny4knqZesHWyn0v57vN0iaA_1ZUae997M2O91cxRigKZ5S_AHgpn6mDnhRLeYshZLymTbvWhOKOak5Urpo__y4-Ys5w2uhzFMhXzVHLNO405QdtJMNzZNUHyY0Pb75cWPlqIS0ZJigaEgO1kfco3DWgD98i7ADvmwWdMO3Xlb01vf--JjQHFEI6QUlxKzz8jBAsFBKKjWFsHeNC9HO2c4e4inzc8vFzfnX9vrb5dX55-v20EQVVpLh5FrNygJHeZUU6dIh3Hfa6B8BMkcFlR21MmRYE250q7WqdZES8eJZKfN1UHXRbsxS_Jbm3YmWm_uL2KajE3FDzMYSvqeKOi5BsKZID0XFGumFNVi7EdRtT4dtJa134Ib6jbJzo9EH1eCvzVTvDMES6KEZFXh_YNCir9XyMVsfR5gnm2AuGZDlao9ORZ76Lsn0E1cU6hvtUdxrmWH9yh1QA0p5pxgNIMvdv8BdQA_185m7w5zcIep7jD37jBdpdIn1L-LPEtiB1Ku4DBB-jfVM6w_lp_LHQ
CitedBy_id crossref_primary_10_1016_j_celrep_2024_114075
crossref_primary_10_1007_s12011_023_04044_w
crossref_primary_10_1007_s11010_024_05056_3
crossref_primary_10_1016_j_foodchem_2024_140821
crossref_primary_10_12677_acm_2024_1451418
crossref_primary_10_1016_j_jpha_2024_03_001
crossref_primary_10_1002_ddr_70044
crossref_primary_10_1371_journal_pone_0307472
crossref_primary_10_1038_s42003_024_07377_x
Cites_doi 10.1016/j.tcb.2015.10.014
10.1038/s41572-021-00284-z
10.1073/pnas.96.13.7220
10.1111/j.1523-1755.2004.00493.x
10.1038/cdd.2015.158
10.1056/NEJMra1805256
10.1080/15548627.2020.1810918
10.1016/j.cell.2012.03.042
10.1016/j.jacc.2020.06.070
10.1681/ASN.2019060570
10.1016/j.prostaglandins.2008.10.003
10.1007/s00134-021-06454-7
10.1039/C9CS00268E
10.1136/bmj.k4891
10.1681/ASN.2015060647
10.1038/s41581-023-00694-0
10.1681/ASN.2015121376
10.1016/S0140-6736(17)31329-6
10.1016/j.celrep.2014.02.042
10.1038/s41419-022-04628-9
10.1016/j.cmet.2020.10.011
10.1016/j.prostaglandins.2017.10.006
10.1161/01.RES.0000251306.40546.08
10.1021/bi700605m
10.1016/j.kint.2022.01.029
10.3389/fphar.2014.00061
10.1038/ki.2010.331
10.1152/ajprenal.00044.2017
10.1074/jbc.M112.418475
10.1016/S0140-6736(19)32563-2
10.1016/j.pharmthera.2016.03.015
10.1016/j.jhep.2014.07.018
10.1016/j.cell.2020.04.039
10.1681/ASN.2013080902
10.1038/ncb3064
10.1016/j.redox.2021.102021
10.1128/MCB.02314-06
10.1038/mp.2016.196
10.1161/HYPERTENSIONAHA.111.178897
10.1038/nature14344
10.1046/j.1523-1755.1998.00767.x
10.1038/s41418-022-00943-y
10.1038/s42255-022-00536-6
ContentType Journal Article
Copyright The Author(s) 2023
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. The Author(s).
Copyright_xml – notice: The Author(s) 2023
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41419-023-06236-7
DatabaseName SpringerOpen
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-4889
EndPage 12
ExternalDocumentID oai_doaj_org_article_21bb18eb49e14351b45209388295fbf5
PMC10618563
10_1038_s41419_023_06236_7
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81603179; 82000683
  funderid: https://doi.org/10.13039/501100001809
– fundername: ;
  grantid: 81603179; 82000683
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
E3Z
EBLON
EBS
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c518t-a2cf49dc86e704292d81700bb9e24fe63d052672d6f1092489d170299196d4163
IEDL.DBID 7X7
ISSN 2041-4889
IngestDate Wed Aug 27 01:24:47 EDT 2025
Thu Aug 21 18:36:38 EDT 2025
Mon Jul 21 10:15:44 EDT 2025
Wed Aug 13 11:32:41 EDT 2025
Tue Jul 01 03:50:11 EDT 2025
Thu Apr 24 22:50:22 EDT 2025
Fri Feb 21 02:36:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c518t-a2cf49dc86e704292d81700bb9e24fe63d052672d6f1092489d170299196d4163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1720-8540
0000-0002-3107-0429
OpenAccessLink https://www.proquest.com/docview/2884496703?pq-origsite=%requestingapplication%
PMID 37907523
PQID 2884496703
PQPubID 2041963
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_21bb18eb49e14351b45209388295fbf5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10618563
proquest_miscellaneous_2885204053
proquest_journals_2884496703
crossref_citationtrail_10_1038_s41419_023_06236_7
crossref_primary_10_1038_s41419_023_06236_7
springer_journals_10_1038_s41419_023_06236_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-10-31
PublicationDateYYYYMMDD 2023-10-31
PublicationDate_xml – month: 10
  year: 2023
  text: 2023-10-31
  day: 31
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationYear 2023
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Martin-Sanchez, Ruiz-Andres, Poveda, Carrasco, Cannata-Ortiz, Sanchez-Nino (CR36) 2017; 28
Yang, Stockwell (CR42) 2016; 26
CR19
Chiabrando, Vinchi, Fiorito, Mercurio, Tolosano (CR27) 2014; 5
Zheng, Conrad (CR40) 2020; 32
Shen, Sheng, Chang, Wu, Wang, Xuan (CR26) 2014; 7
Lieberthal, Triaca, Levine (CR30) 1996; 270
Xu, Jia, Fang, Jin, Sun, Zhou (CR45) 2022; 101
Ni, Yuan, Wu (CR22) 2022; 13
Jang, Chapa-Dubocq, Tyurina, St Croix, Kapralov, Tyurin (CR41) 2021; 45
Pickkers, Darmon, Hoste, Joannidis, Legrand, Ostermann (CR6) 2021; 47
Shimizu, Lengalova, Martinek, Martinkova (CR28) 2019; 48
Jentzer, Bihorac, Brusca, Del Rio-Pertuz, Kashani, Kazory (CR7) 2020; 76
Jiang, Kon, Li, Wang, Su, Hibshoosh (CR25) 2015; 520
Mehran, Dangas, Weisbord (CR3) 2019; 380
Wang, Liu, Zhang, Yang, Chen (CR11) 2018; 134
Jania, Chandrasekharan, Backlund, Foley, Snouwaert, Wang (CR21) 2009; 88
Takusagawa (CR17) 2013; 288
Ronco, Bellomo, Kellum (CR2) 2019; 394
Kellum, Romagnani, Ashuntantang, Ronco, Zarbock, Anders (CR1) 2021; 7
Cardoso, Hare, Bush, Roberts (CR43) 2017; 22
Yang, Song, Liu, Liu, Sun, Peng (CR8) 2016; 163
Adedoyin, Boddu, Traylor, Lever, Bolisetty, George (CR38) 2018; 314
Dixon, Lemberg, Lamprecht, Skouta, Zaitsev, Gleason (CR23) 2012; 149
Yamada, Takusagawa (CR18) 2007; 46
Friedmann Angeli, Schneider, Proneth, Tyurina, Tyurin, Hammond (CR33) 2014; 16
Mishima, Sato, Ito, Yamada, Suzuki, Oikawa (CR37) 2020; 31
Chen, Li, Kang, Klionsky, Tang (CR39) 2021; 17
Lovgren, Kovarova, Koller (CR12) 2007; 27
Sun, Jia, Yang, Kakizoe, Liu, Yang (CR20) 2014; 61
Jia, Wang, Yang (CR16) 2012; 59
Jia, Wang, Aoyagi, Wang, Liu, Yang (CR14) 2011; 79
Takaori, Nakamura, Yamamoto, Nakata, Sato, Takase (CR29) 2016; 27
CR24
Jia, Zhang, Zhang, Dong, Yang (CR15) 2006; 99
Sanz, Sanchez-Nino, Ramos, Ortiz (CR32) 2023; 19
Xie, Hou, Song, Yu, Huang, Sun (CR35) 2016; 23
Jakobsson, Thoren, Morgenstern, Samuelsson (CR10) 1999; 96
Poston, Koyner (CR4) 2019; 364
Baliga, Zhang, Baliga, Ueda, Shah (CR31) 1998; 53
Schneider, Zhang, Zhang, Lu, Rao, Fan (CR13) 2004; 65
Zhang, Liu, Wei, Huo, Liu, Liu (CR44) 2014; 25
Vanmassenhove, Kielstein, Jorres, Biesen (CR5) 2017; 389
Kudo, Murakami (CR9) 2005; 38
Hadian, Stockwell (CR34) 2020; 181
S Xu (6236_CR45) 2022; 101
L Jiang (6236_CR25) 2015; 520
I Kudo (6236_CR9) 2005; 38
Y Sun (6236_CR20) 2014; 61
SJ Dixon (6236_CR23) 2012; 149
D Chiabrando (6236_CR27) 2014; 5
Z Jia (6236_CR14) 2011; 79
D Zhang (6236_CR44) 2014; 25
WS Yang (6236_CR42) 2016; 26
BR Cardoso (6236_CR43) 2017; 22
J Vanmassenhove (6236_CR5) 2017; 389
JP Friedmann Angeli (6236_CR33) 2014; 16
K Takaori (6236_CR29) 2016; 27
L Ni (6236_CR22) 2022; 13
K Hadian (6236_CR34) 2020; 181
T Yamada (6236_CR18) 2007; 46
O Adedoyin (6236_CR38) 2018; 314
Y Yang (6236_CR8) 2016; 163
E Mishima (6236_CR37) 2020; 31
Z Jia (6236_CR16) 2012; 59
X Chen (6236_CR39) 2021; 17
Z Jia (6236_CR15) 2006; 99
6236_CR24
AK Lovgren (6236_CR12) 2007; 27
JT Poston (6236_CR4) 2019; 364
Y Xie (6236_CR35) 2016; 23
P Pickkers (6236_CR6) 2021; 47
A Schneider (6236_CR13) 2004; 65
F Takusagawa (6236_CR17) 2013; 288
AB Sanz (6236_CR32) 2023; 19
J Wang (6236_CR11) 2018; 134
PJ Jakobsson (6236_CR10) 1999; 96
R Baliga (6236_CR31) 1998; 53
JC Jentzer (6236_CR7) 2020; 76
W Lieberthal (6236_CR30) 1996; 270
LA Jania (6236_CR21) 2009; 88
J Shen (6236_CR26) 2014; 7
J Zheng (6236_CR40) 2020; 32
T Shimizu (6236_CR28) 2019; 48
S Jang (6236_CR41) 2021; 45
C Ronco (6236_CR2) 2019; 394
JA Kellum (6236_CR1) 2021; 7
R Mehran (6236_CR3) 2019; 380
D Martin-Sanchez (6236_CR36) 2017; 28
6236_CR19
References_xml – volume: 26
  start-page: 165
  year: 2016
  end-page: 76
  ident: CR42
  article-title: Ferroptosis: Death by Lipid Peroxidation
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2015.10.014
– volume: 7
  start-page: 52
  year: 2021
  ident: CR1
  article-title: Acute kidney injury
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-021-00284-z
– volume: 96
  start-page: 7220
  year: 1999
  end-page: 5
  ident: CR10
  article-title: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.96.13.7220
– volume: 65
  start-page: 1205
  year: 2004
  end-page: 13
  ident: CR13
  article-title: Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00493.x
– volume: 23
  start-page: 369
  year: 2016
  end-page: 79
  ident: CR35
  article-title: Ferroptosis: process and function
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2015.158
– volume: 38
  start-page: 633
  year: 2005
  end-page: 8
  ident: CR9
  article-title: Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis
  publication-title: J Biochem Mol Biol
– volume: 380
  start-page: 2146
  year: 2019
  end-page: 55
  ident: CR3
  article-title: Contrast-Associated Acute Kidney Injury
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1805256
– volume: 17
  start-page: 2054
  year: 2021
  end-page: 81
  ident: CR39
  article-title: Ferroptosis: machinery and regulation
  publication-title: Autophagy
  doi: 10.1080/15548627.2020.1810918
– volume: 149
  start-page: 1060
  year: 2012
  end-page: 72
  ident: CR23
  article-title: Ferroptosis: an iron-dependent form of nonapoptotic cell death
  publication-title: Cell
  doi: 10.1016/j.cell.2012.03.042
– volume: 270
  start-page: F700
  year: 1996
  end-page: 8
  ident: CR30
  article-title: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis
  publication-title: Am J Physiol
– volume: 76
  start-page: 1084
  year: 2020
  end-page: 101
  ident: CR7
  article-title: Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.06.070
– volume: 31
  start-page: 280
  year: 2020
  end-page: 96
  ident: CR37
  article-title: Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2019060570
– volume: 88
  start-page: 73
  year: 2009
  end-page: 81
  ident: CR21
  article-title: Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E-2 biosynthesis
  publication-title: Prostag Oth Lipid M
  doi: 10.1016/j.prostaglandins.2008.10.003
– volume: 47
  start-page: 835
  year: 2021
  end-page: 50
  ident: CR6
  article-title: Acute kidney injury in the critically ill: an updated review on pathophysiology and management
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-021-06454-7
– volume: 48
  start-page: 5624
  year: 2019
  end-page: 57
  ident: CR28
  article-title: Heme: emergent roles of heme in signal transduction, functional regulation and as catalytic centres
  publication-title: Chem Soc Rev
  doi: 10.1039/C9CS00268E
– volume: 364
  start-page: k4891
  year: 2019
  ident: CR4
  article-title: Sepsis associated acute kidney injury
  publication-title: BMJ
  doi: 10.1136/bmj.k4891
– volume: 27
  start-page: 2393
  year: 2016
  end-page: 406
  ident: CR29
  article-title: Severity and Frequency of Proximal Tubule Injury Determines Renal Prognosis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015060647
– volume: 19
  start-page: 281
  year: 2023
  end-page: 99
  ident: CR32
  article-title: Regulated cell death pathways in kidney disease
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-023-00694-0
– volume: 28
  start-page: 218
  year: 2017
  end-page: 29
  ident: CR36
  article-title: Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015121376
– volume: 389
  start-page: 2139
  year: 2017
  end-page: 51
  ident: CR5
  article-title: Management of patients at risk of acute kidney injury
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31329-6
– ident: CR19
– volume: 7
  start-page: 180
  year: 2014
  end-page: 93
  ident: CR26
  article-title: Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.02.042
– volume: 13
  year: 2022
  ident: CR22
  article-title: Targeting ferroptosis in acute kidney injury
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04628-9
– volume: 32
  start-page: 920
  year: 2020
  end-page: 37
  ident: CR40
  article-title: The Metabolic Underpinnings of Ferroptosis
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2020.10.011
– volume: 134
  start-page: 1
  year: 2018
  end-page: 6
  ident: CR11
  article-title: Physiological and pathophysiological implications of PGE2 and the PGE2 synthases in the kidney
  publication-title: Prostaglandins Other Lipid Mediat
  doi: 10.1016/j.prostaglandins.2017.10.006
– volume: 99
  start-page: 1243
  year: 2006
  end-page: 51
  ident: CR15
  article-title: Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000251306.40546.08
– volume: 46
  start-page: 8414
  year: 2007
  end-page: 24
  ident: CR18
  article-title: PGH2 degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: the first example of a dual-function enzyme
  publication-title: Biochemistry
  doi: 10.1021/bi700605m
– volume: 101
  start-page: 987
  year: 2022
  end-page: 1002
  ident: CR45
  article-title: Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2022.01.029
– volume: 5
  start-page: 61
  year: 2014
  ident: CR27
  article-title: Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2014.00061
– volume: 79
  start-page: 77
  year: 2011
  end-page: 88
  ident: CR14
  article-title: Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis
  publication-title: Kidney Int
  doi: 10.1038/ki.2010.331
– volume: 314
  start-page: F702
  year: 2018
  end-page: F14
  ident: CR38
  article-title: Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00044.2017
– volume: 288
  start-page: 10166
  year: 2013
  end-page: 75
  ident: CR17
  article-title: Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.418475
– volume: 394
  start-page: 1949
  year: 2019
  end-page: 64
  ident: CR2
  article-title: Acute kidney injury
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32563-2
– volume: 163
  start-page: 58
  year: 2016
  end-page: 73
  ident: CR8
  article-title: Renoprotective approaches and strategies in acute kidney injury
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2016.03.015
– volume: 61
  start-page: 1328
  year: 2014
  end-page: 36
  ident: CR20
  article-title: mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.07.018
– volume: 181
  start-page: 1188
  year: 2020
  end-page: e1
  ident: CR34
  article-title: SnapShot: Ferroptosis
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.039
– volume: 25
  start-page: 2278
  year: 2014
  end-page: 89
  ident: CR44
  article-title: Tubular p53 regulates multiple genes to mediate AKI
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013080902
– volume: 16
  start-page: 1180
  year: 2014
  end-page: 91
  ident: CR33
  article-title: Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3064
– volume: 45
  start-page: 102021
  year: 2021
  ident: CR41
  article-title: Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2021.102021
– volume: 27
  start-page: 4416
  year: 2007
  end-page: 30
  ident: CR12
  article-title: cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.02314-06
– volume: 22
  start-page: 328
  year: 2017
  end-page: 35
  ident: CR43
  article-title: Glutathione peroxidase 4: a new player in neurodegeneration?
  publication-title: Mol Psych
  doi: 10.1038/mp.2016.196
– volume: 59
  start-page: 122
  year: 2012
  end-page: 8
  ident: CR16
  article-title: Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.178897
– volume: 520
  start-page: 57
  year: 2015
  end-page: 62
  ident: CR25
  article-title: Ferroptosis as a p53-mediated activity during tumour suppression
  publication-title: Nature
  doi: 10.1038/nature14344
– ident: CR24
– volume: 53
  start-page: 394
  year: 1998
  end-page: 401
  ident: CR31
  article-title: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1998.00767.x
– volume: 5
  start-page: 61
  year: 2014
  ident: 6236_CR27
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2014.00061
– volume: 288
  start-page: 10166
  year: 2013
  ident: 6236_CR17
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.418475
– volume: 27
  start-page: 2393
  year: 2016
  ident: 6236_CR29
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015060647
– volume: 26
  start-page: 165
  year: 2016
  ident: 6236_CR42
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2015.10.014
– volume: 28
  start-page: 218
  year: 2017
  ident: 6236_CR36
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015121376
– volume: 47
  start-page: 835
  year: 2021
  ident: 6236_CR6
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-021-06454-7
– volume: 380
  start-page: 2146
  year: 2019
  ident: 6236_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1805256
– volume: 364
  start-page: k4891
  year: 2019
  ident: 6236_CR4
  publication-title: BMJ
  doi: 10.1136/bmj.k4891
– volume: 65
  start-page: 1205
  year: 2004
  ident: 6236_CR13
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00493.x
– ident: 6236_CR24
  doi: 10.1038/s41418-022-00943-y
– volume: 88
  start-page: 73
  year: 2009
  ident: 6236_CR21
  publication-title: Prostag Oth Lipid M
  doi: 10.1016/j.prostaglandins.2008.10.003
– volume: 394
  start-page: 1949
  year: 2019
  ident: 6236_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32563-2
– volume: 79
  start-page: 77
  year: 2011
  ident: 6236_CR14
  publication-title: Kidney Int
  doi: 10.1038/ki.2010.331
– volume: 59
  start-page: 122
  year: 2012
  ident: 6236_CR16
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.178897
– volume: 389
  start-page: 2139
  year: 2017
  ident: 6236_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)31329-6
– volume: 46
  start-page: 8414
  year: 2007
  ident: 6236_CR18
  publication-title: Biochemistry
  doi: 10.1021/bi700605m
– volume: 22
  start-page: 328
  year: 2017
  ident: 6236_CR43
  publication-title: Mol Psych
  doi: 10.1038/mp.2016.196
– volume: 61
  start-page: 1328
  year: 2014
  ident: 6236_CR20
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.07.018
– volume: 134
  start-page: 1
  year: 2018
  ident: 6236_CR11
  publication-title: Prostaglandins Other Lipid Mediat
  doi: 10.1016/j.prostaglandins.2017.10.006
– volume: 7
  start-page: 52
  year: 2021
  ident: 6236_CR1
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-021-00284-z
– volume: 7
  start-page: 180
  year: 2014
  ident: 6236_CR26
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.02.042
– volume: 31
  start-page: 280
  year: 2020
  ident: 6236_CR37
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2019060570
– volume: 25
  start-page: 2278
  year: 2014
  ident: 6236_CR44
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013080902
– volume: 314
  start-page: F702
  year: 2018
  ident: 6236_CR38
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00044.2017
– volume: 520
  start-page: 57
  year: 2015
  ident: 6236_CR25
  publication-title: Nature
  doi: 10.1038/nature14344
– volume: 53
  start-page: 394
  year: 1998
  ident: 6236_CR31
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1998.00767.x
– volume: 99
  start-page: 1243
  year: 2006
  ident: 6236_CR15
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000251306.40546.08
– volume: 96
  start-page: 7220
  year: 1999
  ident: 6236_CR10
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.96.13.7220
– volume: 17
  start-page: 2054
  year: 2021
  ident: 6236_CR39
  publication-title: Autophagy
  doi: 10.1080/15548627.2020.1810918
– volume: 32
  start-page: 920
  year: 2020
  ident: 6236_CR40
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2020.10.011
– volume: 27
  start-page: 4416
  year: 2007
  ident: 6236_CR12
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.02314-06
– volume: 38
  start-page: 633
  year: 2005
  ident: 6236_CR9
  publication-title: J Biochem Mol Biol
– volume: 149
  start-page: 1060
  year: 2012
  ident: 6236_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2012.03.042
– volume: 19
  start-page: 281
  year: 2023
  ident: 6236_CR32
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-023-00694-0
– volume: 16
  start-page: 1180
  year: 2014
  ident: 6236_CR33
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3064
– volume: 101
  start-page: 987
  year: 2022
  ident: 6236_CR45
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2022.01.029
– volume: 45
  start-page: 102021
  year: 2021
  ident: 6236_CR41
  publication-title: Redox Biol
  doi: 10.1016/j.redox.2021.102021
– volume: 270
  start-page: F700
  year: 1996
  ident: 6236_CR30
  publication-title: Am J Physiol
– volume: 163
  start-page: 58
  year: 2016
  ident: 6236_CR8
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2016.03.015
– ident: 6236_CR19
  doi: 10.1038/s42255-022-00536-6
– volume: 23
  start-page: 369
  year: 2016
  ident: 6236_CR35
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2015.158
– volume: 48
  start-page: 5624
  year: 2019
  ident: 6236_CR28
  publication-title: Chem Soc Rev
  doi: 10.1039/C9CS00268E
– volume: 181
  start-page: 1188
  year: 2020
  ident: 6236_CR34
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.039
– volume: 76
  start-page: 1084
  year: 2020
  ident: 6236_CR7
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.06.070
– volume: 13
  year: 2022
  ident: 6236_CR22
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04628-9
SSID ssj0000330256
Score 2.4271727
Snippet Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2 (mPGES-2) is...
Abstract Acute kidney injury (AKI) is a clinical syndrome with high morbidity and mortality but no specific therapy. Microsomal prostaglandin E synthase-2...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 710
SubjectTerms 13/1
13/109
13/89
14/19
14/28
45/90
45/91
631/80/82
692/699/1585/4
Antibodies
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cell Culture
Cell injury
Cisplatin
Ferroptosis
Heme
Immunology
Ischemia
Kidneys
Life Sciences
Morbidity
p53 Protein
Prostaglandin E
Prostaglandin E2
Renal function
Reperfusion
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9UwFA4yGPgiOhWvbhLBNy1b0iRNHzfZHIIiuMHeQn5u1dle7u0V9t_vnLT3ug7UF98uTdLb5pz0-05z-h1C3gYWU-msLyzgCwQoZSqslLLQzjKgz5ZHh-8hP39Rp-fi04W8uFPqC3PCBnngYeL2OXOOaRhRR4R25gQmbpRADGuZXMrqpYB5d4Kp_AyGMB3AfPxK5qDU-0vBBH6vw7GYAS9VUU2QKAv2T1jm_RzJexulGX9OHpNHI3Gkh8MFPyEPYrtDtodSkjdPyeVZTumGofTn14_H3wpO-46OKgzUXtoGeCC1ftVH-qMJbbyhTfsdJpT-aiz8vGpcTt6iXaIpLhbdvO-WzZKui-T2FNrmsnxGzk-Ozz6cFmMRhcJLpvvCcp9EHbxWsULw4SFL8jlXRy5SVGVAxZeKB5XYAQRjug7QDiAFSzMgW3tOttqujS8IjTIyBXwFK5QL7ZnzPnE0dB2rEKSaEbaeUONHhXEsdHFt8k53qc1gBANGMNkIppqRd5sx80Ff46-9j9BOm56ojZ0PgMeY0WPMvzxmRnbXVjbjgl0arrUQtYLn34y82TTDUsP9E9vGbpX7wJmA4UIfPfGOyQVNW9rmKot2Y-itpYKh79eO9Pvf_3zHL__HHb8iDzk6fobcXbLVL1ZxD7hU717nZXMLnUsXdg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKERKXiqdYKMhI3CCAHdtxDggBaqmQipDoSr1Zfm4DJdlms4j994ydZFGq0lsU24njmfF8E9vzIfTCER9yo22mwb9AgJKHTHPOM2k0AfisqTfxP-TxV3E0Z19O-ekOGumOhgFcXRnaRT6peXv--s_F5j0Y_Lv-yLh8s2KExaM4NPIU0FxkxQ10EzxTERkNjge4n2ZmCN7BxQ9nZ65uOvFPKY3_BHte3jl5afk0eaXDO2hvgJP4Qy__u2jH1_fQrZ5gcnMfLU7SRm9oin99-3zwPaO4a_CQmwHrha4AHWJt153HPytX-w2u6h8wzPh3peHyrDJpSxduAg6-bZtl16yqFR6pczsMZUueP0Dzw4OTT0fZQK2QWU5kl2lqAyudlcIX0SVRlxL1GVN6yoIXuYt5YArqRCBvIUSTpYNycF1gsC5iuIdot25q_whhzz0RgGIibzmTlhhrA43iL33hHBczRMYBVXbIOx7pL85VWv_OpeqFoEAIKglBFTP0cttm2WfduLb2xyinbc2YMTvdaNqFGgxQUWIMkaB5pY8QkRgWNwDlEGCUPJjAZ2h_lLIatVBRKRkrBcyKM_R8WwwGGFdVdO2bdaoDTwLcC3XkRDsmHZqW1NVZSuUdA3LJBTR9NSrSv7f__4sfX9_ZJ-g2jSqdXOw-2u3atX8K2Kkzz5JB_AWLDhMv
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBddy2AvZZ8sW1c02NtmFsmSLD9mo10JbAzaQt-EPlN3mx1ip9D_fifFTnHZCn2ysU62rDvp7qTT7xD64IgPudE206BfwEHJQ6Y555k0moD5rKk3cR3y-w9xcs7mF_xiB9HhLEwK2k-QlmmaHqLDPreMsHjchsZcBDQXWfEI7UWodpDtvdlsfjrfrqxMwUUHRd6fkJnm8h-VR1oogfWPLMy78ZF3NkmT7jl-ivZ7oxHPNs18hnZ8_Rw93qSRvHmBFmcpnBuq4j8_vx2dZhR3De4RGLBegPPfwtWuO49_Va72N7iqr6Az8XWl4fayMilwCzcBB79aNcuuaasWDwlyOwxlS56_ROfHR2dfT7I-gUJmOZFdpqkNrHRWCl9ExUNdguMzpvSUBS9yF9FeCupEIFNwxGTpoBwUFAxLFy21V2i3bmr_GmHPPRFgq8Ts5ExaYqwNNDK59IVzXEwQGTpU2R5dPCa5-K3SLncu1YYJCpigEhNUMUEft3WWG2yNe6m_RD5tKSMudnrQrBaqlxNFiTFEgnyVPhqCxLAY5pODG1HyYAKfoIOBy6ofrK2iUjJWCpj7Juj9thiGWdw70bVv1okG3gTWLdDIkXSMGjQuqavLBNgd3W7JBVT9NAjS7df__8dvHkb-Fj2hUcSTYj1Au91q7d-BxdSZw36I_AW_1A8b
  priority: 102
  providerName: Springer Nature
Title Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53
URI https://link.springer.com/article/10.1038/s41419-023-06236-7
https://www.proquest.com/docview/2884496703
https://www.proquest.com/docview/2885204053
https://pubmed.ncbi.nlm.nih.gov/PMC10618563
https://doaj.org/article/21bb18eb49e14351b45209388295fbf5
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdby2AvY58sWxc02NtmGsmWLT-NNKQrgZaytpA3IVly6m6zs9gZ9GV_--4UOSWF9cU2luSvu9P97nS-I-STZa6MjS4iDfoFDJS4jLQQIpJGM4DPmjuDfsjTs_TkKpnNxTw43NoQVtnPiX6itk2BPvJDLmWS5Ckw6Nfl7wirRuHqaiih8ZjsY-oy5Opsnm19LCMw1kGlh39lRrE8bBOW4F87HEsa8DiNsh195NP272DN-5GS95ZLvRY6fk6eBfhIxxt6vyCPXP2SPNkUlLx9RRaXPrAbhtJf59-mFxGnXUNDLgaqF7oCNEh1se4c_VHZ2t3Sqr6Bz0r_VBoOryvjQ7hoU9LSrVbNsmvaqqV9qdyOQttSxK_J1fH0cnIShVIKUSGY7CLNizLJbSFTl6EK4tYn5jMmdzwpXRpbzPuScZuWbAQmmcwttIOqAgG1iNnekL26qd1bQp1wLAXUgnXKE1kwUxQlR3LnLrNWpAPC-g-qipBnHMtd_FR-vTuWakMEBURQnggqG5DP2zHLTZaNB3sfIZ22PTFDtj_RrBYqCJzizBgmgdNyh5CQmQQDfmIwKHJRmlIMyEFPZRXEtlV3TDYgH7fNIHC4iqJr16x9H7gS4FzoI3e4Y-eBdlvq6tqn7kYDXIoUhn7pGenu7v9_43cPP-x78pQjS3uVekD2utXafQCs1JmhF4gh2R-PZxcz2B9Nz86_w9lJOhl6_wNsTxOJ27_TfzuuFxU
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIIXxKfoGGAkeIJotRMnzgNCfGx07ENIdFLfjB07XRgkpUlB_af4G7lzkk6dxN72FtV2kuZ-vvudfb4j5IVlLg-NzgIN9gUclDAPtBAikEYzoM-aO4PrkEfH8egk-jwRkw3ytz8Lg2GVvU70itpWGa6R73ApoyiNAaBvZ78CrBqFu6t9CY0WFgdu-QdctvrN_keQ70vO93bHH0ZBV1UgyASTTaB5lkepzWTsEtTG3Pocdcakjke5i0OLKVASbuOcDcE7kamFdtDagFWL9AXue41cB8M7RGcvmSSrNZ1hGCKF6M7mDEO5U0cswlNCHEso8DAOkjX758sErHHbi5GZF7ZnvdXbu0Nud3SVvmvxdZdsuPIeudEWsFzeJ9OxDySHofTnl0-7XwNOm4p2uR-onuoC2CfV2aJx9KywpVvSovwOYqS_Cw2Xp4XxIWO0ymnu5vNq1lR1UdO-NG9DoW0mwgfk5Eo-8kOyWVale0SoE47FwJKwLnokM2ayLOcIr9Ql1op4QFj_QVXW5TXH8ho_lN9fD6VqhaBACMoLQSUD8mo1ZtZm9bi093uU06onZuT2P1TzqeomuOLMGCYB2alDCspMhAFGITgwqchNLgZku5ey6tRErc5BPSDPV80wwXHXRpeuWvg-cCfg1dBHrqFj7YXWW8ri1KcKR4dfihiGvu6BdP70___jrctf9hm5ORofHarD_eODx-QWR3h7c75NNpv5wj0BntaYp35yUPLtqmfjPzF5SjU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJxAviE9RGGAkeIKotRMnzgNCjLVsDKoKNmlvmR3bXfhISpuC-q_x13HnJp06ib3tLartJM397vw7-3xHyAvDrAu1ygMF8ws4KKELlBAikFoxoM-KW43rkJ9H8f5x9PFEnGyRv-1ZGAyrbG2iN9SmynGNvMeljKI0BoD2XBMWMd4bvp3-CrCCFO60tuU0VhA5tMs_4L7N3xzsgaxfcj4cHL3fD5oKA0EumKwDxXMXpSaXsU3QMnPj89VpnVoeORuHBtOhJNzEjvXBU5GpgXaw4IBbg1QG7nuNbCfoFXXI9u5gNP6yXuHphyESiuakTj-UvXnEIjwzxLGgAg_jINmYDX3RgA2mezFO88JmrZ8Dh7fJrYa80ncrtN0hW7a8S66vylku75HJkQ8rh6H05_jD4GvAaV3RJhMEVRNVABelKl_Uln4vTGmXtCi_gVDp70LB5VmhfQAZrRx1djarpnU1L-a0LdRbU2ibivA-Ob6Sz_yAdMqqtA8JtcKyGDgTVkmPZM50njuOYEttYoyIu4S1HzTLmyznWGzjR-Z320OZrYSQgRAyL4Qs6ZJX6zHTVY6PS3vvopzWPTE_t_-hmk2yRt0zzrRmEnCeWiSkTEcYbhSCO5MKp53okp1WylljNObZOcS75Pm6GdQd93BUaauF7wN3ApYNfeQGOjZeaLOlLM584nB0_6WIYejrFkjnT___P350-cs-IzdAE7NPB6PDx-QmR3T7uX2HdOrZwj4B0lbrp412UHJ61Qr5D4ubT9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+mPGES-2+to+protect+against+acute+kidney+injury+via+inhibition+of+ferroptosis+dependent+on+p53&rft.jtitle=Cell+death+%26+disease&rft.au=Zhong%2C+Dandan&rft.au=Quan%2C+Lingling&rft.au=Hao%2C+Chang&rft.au=Chen%2C+Jingshuo&rft.date=2023-10-31&rft.pub=Springer+Nature+B.V&rft.eissn=2041-4889&rft.volume=14&rft.issue=10&rft.spage=710&rft_id=info:doi/10.1038%2Fs41419-023-06236-7&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon